PDF(Pubmed)
Abstract：
UNASSIGNED: Pectoralis minor syndrome involves pain, paraesthesia and weakness in the arm due to compression of the brachial plexus passing beneath pectoralis minor; this paper reports the results of a single centre\'s treatment pathway in affected patients.
UNASSIGNED: During a four-year period, patients exhibiting symptoms of pectoralis minor syndrome without significant improvement following physiotherapy proceeded to Botulinum injection. Those with good response to injection but subsequent recurrence of symptoms were offered pectoralis minor tenotomy. Oxford shoulder Scores were collected at baseline and after interventions.
UNASSIGNED: Twenty-one patients received Botulinum injection; at six weeks following injection, mean change in Oxford Shoulder Score was +12.4, with only one patient reporting a worsening of symptoms. Of the 17 patients with clinically significant response to injection, 12 have subsequently undergone tenotomy; three months following tenotomy, mean change in Oxford Shoulder Score from baseline was +22.3. Improvement was maintained in all patients at prolonged follow-up (average 20 months post-tenotomy).
UNASSIGNED: This pathway has shown to be extremely effective in patients not responding to first-line treatment for pectoralis minor syndrome, with 85% of patients post-injection and 100% of patients post-tenotomy showing significant (greater than published minimal clinically important difference value of six points) improvements in Oxford Shoulder Score, maintained at follow-up.
UNASSIGNED: During a four-year period, patients exhibiting symptoms of pectoralis minor syndrome without significant improvement following physiotherapy proceeded to Botulinum injection. Those with good response to injection but subsequent recurrence of symptoms were offered pectoralis minor tenotomy. Oxford shoulder Scores were collected at baseline and after interventions.
UNASSIGNED: Twenty-one patients received Botulinum injection; at six weeks following injection, mean change in Oxford Shoulder Score was +12.4, with only one patient reporting a worsening of symptoms. Of the 17 patients with clinically significant response to injection, 12 have subsequently undergone tenotomy; three months following tenotomy, mean change in Oxford Shoulder Score from baseline was +22.3. Improvement was maintained in all patients at prolonged follow-up (average 20 months post-tenotomy).
UNASSIGNED: This pathway has shown to be extremely effective in patients not responding to first-line treatment for pectoralis minor syndrome, with 85% of patients post-injection and 100% of patients post-tenotomy showing significant (greater than published minimal clinically important difference value of six points) improvements in Oxford Shoulder Score, maintained at follow-up.
摘要：
未经证实：胸肌轻微综合征涉及疼痛，由于臂丛神经在胸小肌下方受压而引起的手臂感觉异常和虚弱；本文报告了受影响患者的单中心治疗途径的结果。
未经批准：在四年期间，在物理治疗后表现出胸肌轻微综合征症状但无明显改善的患者继续注射肉毒杆菌。对注射反应良好但随后症状复发的患者进行胸大肌小腱切开术。在基线和干预后收集牛津肩分数。
未经授权：21名患者接受肉毒杆菌注射；注射后6周，牛津肩评分的平均变化为+12.4,只有1例患者报告症状恶化.在对注射有临床意义的17名患者中，12人随后进行了肌腱切开术；肌腱切开术后三个月，牛津肩评分相对于基线的平均变化为+22.3.所有患者在延长随访时间（平均肌腱切开术后20个月）均保持改善。
UNASSIGNED：该途径已证明对胸小肌综合征一线治疗无效的患者非常有效，85％的患者在注射后和100％的患者在肌腱切开术后显示出牛津肩评分的显着改善（大于公布的6分的最小临床重要差异值），保持后续。
未经批准：在四年期间，在物理治疗后表现出胸肌轻微综合征症状但无明显改善的患者继续注射肉毒杆菌。对注射反应良好但随后症状复发的患者进行胸大肌小腱切开术。在基线和干预后收集牛津肩分数。
未经授权：21名患者接受肉毒杆菌注射；注射后6周，牛津肩评分的平均变化为+12.4,只有1例患者报告症状恶化.在对注射有临床意义的17名患者中，12人随后进行了肌腱切开术；肌腱切开术后三个月，牛津肩评分相对于基线的平均变化为+22.3.所有患者在延长随访时间（平均肌腱切开术后20个月）均保持改善。
UNASSIGNED：该途径已证明对胸小肌综合征一线治疗无效的患者非常有效，85％的患者在注射后和100％的患者在肌腱切开术后显示出牛津肩评分的显着改善（大于公布的6分的最小临床重要差异值），保持后续。
